MODD Modular Medical Inc Accounting Capitalization

Corporate emblem and logo of Modular Medical Inc (MODD)

Modular Medical is mitigating commercial risks through direct sales and partnerships with insurance companies. The company is currently accelerating its development pace, preparing the innovative MODD1 pump for a mass market launch in 2026. The price action on GURU.Markets, where the indicator stands at 0.02, confirms the potential of this US enterprise, which creates user-friendly systems for people with diabetes.

Modular Medical (MODD) - Company Book Value from 07/04/2022 to 10/27/2026

Financial and market metric breakdowns for Modular Med (MODD)

- price and consensus price forecast:
Share Price Modular Medical|MODD - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Modular Medical Inc|MODD - Total Company Value
- book capitalization data:
Net Assets per Share Modular Medical|MODD - Company Book Value|Market Capitalization to Net Assets modular-medical.com|MODD - Company Total Assets
- debt and liquidity data:
Debt to Capital Modular Medical|MODD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Modular Medical|MODD - Company Aggregate Debts|Debts to Net Assets Modular Medical Inc
Summary company analytics:MODD - Modular Medical, Inc.
Mass-produced product of modular-medical.com

For Modular Medical (MODD), the book value of equity chart reflects the dynamics of net assets minus all liabilities, capturing the real intrinsic value of the business. The growth of this indicator confirms the capitalization of profits from high-margin insulin pump consumables, allowing investors to assess the company's fundamental stability and avoid overpaying relative to its actual value.

Competitor analysis for Modular Medical

BSX - Accounting Capitalization|Book Capitalization Edwards Lifesciences|RMD (resmed.com) - Accounting Capitalization|PODD: Company Book Value|Book Valuation of Business ZBH|COO - Company Book Value|Net Asset Value Align Corp (ALGN)|GMED: Book Capitalization|Total Stockholders' Equity TransMedics Organ Care System TMDX|ATEC: Book Capitalization|AORT - Company Net Assets|DJO Global - Book Capitalization|Integra LifeSciences Inc. (IART) - Book Valuation of Business|ESTA (Establishment Labs) - Book Capitalization|Book Capitalization BBNX|Company Book Value IRADIMED (IRMD)|Company Book Value Embecta Corp (EMBC)|Book Capitalization TNDM|AXGN - Book Valuation of Business|Company Net Assets SI-BONE, Inc.|OFIX - Net Asset Value|Book Capitalization BVS|OrthoPediatrics (KIDS) - Total Stockholders' Equity|Book Capitalization Treace Medical (TMCI)|Accounting Capitalization Strata Medical (SRTA)|Carlsmed Inc (CARL) - Company Net Assets|Accounting Value of Company RXST (rxsight.com)|ClearPoint Neuro - Company Book Value|Company Net Assets Stereotaxis Inc STXS|STIM (NeuroStar) - Book Capitalization|SGHT - Total Stockholders' Equity|Book Capitalization Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Accounting Capitalization|NSPR: Book Capitalization|Book Valuation of Business Jin Medical International Ltd|Book Capitalization VANI (Vivani Medical, Inc.)|Company Net Assets xtantmedical.com (XTNT)|Book Capitalization NMTC (NeuroOne Medical Technologies)|myomo.com - Book Capitalization|COCH - Company Book Value|Vivos Therapeutics Inc. (VVOS) - Company Book Value|Company Net Assets enVVeno NVNO|Sintx Technologies, Inc. (SINT) - Accounting Value of Company|Book Capitalization TNON (Tenon Medical, Inc.)|Total Stockholders' Equity LFWD|AMIX: Company Book Value|Book Value of Business INVO Bioscience IVF|Company Net Assets BBLG (Bone Biologics Corporation)|Book Capitalization Axonics, Inc AXNX|Book Capitalization BIOL (BIOLASE, Inc.)|DYNT: Book Valuation of Business|Company Book Value paragon28.com (FNA)|INVO (INVO Bioscience) - Net Asset Value